Inhibition of miR-155 reduces impaired autophagy and improves prognosis in an experimental pancreatitis mouse model

Jianhua Wan, Xiaoyu Yang, Yuping Ren, Xueyang Li, Yin Zhu, Ashley N. Haddock, Baoan D Ji, Liang Xia, Nonghua Lu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Acute pancreatitis (AP) is a common digestive disease characterized by inflammation of the pancreas. MiR-155 plays a role in promoting inflammation and inhibiting the activation of anti-inflammatory pathways. Impaired autophagy could promote zymogen activation, abnormal acinar cell secretion, cell death, and the inflammatory response to aggravate AP. The aim of this study was to ascertain the effect of silencing miR-155 on AP through its effects on inflammation and impaired autophagy in vivo. In this study, AAV(adeno-associated virus)-mediated miR-155 and miR-155 sponge were injected through the tail vein of mice. After 3 weeks, AP was induced by intraperitoneal (IP) injections of cerulein. Pancreatic and pulmonary tissues were analyzed after 24 h. Silencing of miR-155 ameliorated pancreas and lung damage in three AP models of mice by preventing accumulation of autophagosomes that are unable to fuse with lysosomes and decreasing pancreatic inflammation by targeting TAB2. 3-MA could reduce the aberrant accumulation of autophagosomes, which alleviates the pancreas damage that was aggravated by increasing miR-155 levels. These findings demonstrate that the inhibition of miR-155 holds promise for limiting pancreatitis.

Original languageEnglish (US)
Article number303
JournalCell Death and Disease
Volume10
Issue number4
DOIs
StatePublished - Apr 1 2019

Fingerprint

Autophagy
Pancreatitis
Inflammation
Pancreas
Ceruletide
Lung
Dependovirus
Enzyme Precursors
Acinar Cells
Porifera
Lysosomes
Intraperitoneal Injections
Tail
Veins
Cell Death
Anti-Inflammatory Agents

ASJC Scopus subject areas

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research

Cite this

Inhibition of miR-155 reduces impaired autophagy and improves prognosis in an experimental pancreatitis mouse model. / Wan, Jianhua; Yang, Xiaoyu; Ren, Yuping; Li, Xueyang; Zhu, Yin; Haddock, Ashley N.; Ji, Baoan D; Xia, Liang; Lu, Nonghua.

In: Cell Death and Disease, Vol. 10, No. 4, 303, 01.04.2019.

Research output: Contribution to journalArticle

Wan, Jianhua ; Yang, Xiaoyu ; Ren, Yuping ; Li, Xueyang ; Zhu, Yin ; Haddock, Ashley N. ; Ji, Baoan D ; Xia, Liang ; Lu, Nonghua. / Inhibition of miR-155 reduces impaired autophagy and improves prognosis in an experimental pancreatitis mouse model. In: Cell Death and Disease. 2019 ; Vol. 10, No. 4.
@article{c2e03634acbd446d9b2937163c9dc8f9,
title = "Inhibition of miR-155 reduces impaired autophagy and improves prognosis in an experimental pancreatitis mouse model",
abstract = "Acute pancreatitis (AP) is a common digestive disease characterized by inflammation of the pancreas. MiR-155 plays a role in promoting inflammation and inhibiting the activation of anti-inflammatory pathways. Impaired autophagy could promote zymogen activation, abnormal acinar cell secretion, cell death, and the inflammatory response to aggravate AP. The aim of this study was to ascertain the effect of silencing miR-155 on AP through its effects on inflammation and impaired autophagy in vivo. In this study, AAV(adeno-associated virus)-mediated miR-155 and miR-155 sponge were injected through the tail vein of mice. After 3 weeks, AP was induced by intraperitoneal (IP) injections of cerulein. Pancreatic and pulmonary tissues were analyzed after 24 h. Silencing of miR-155 ameliorated pancreas and lung damage in three AP models of mice by preventing accumulation of autophagosomes that are unable to fuse with lysosomes and decreasing pancreatic inflammation by targeting TAB2. 3-MA could reduce the aberrant accumulation of autophagosomes, which alleviates the pancreas damage that was aggravated by increasing miR-155 levels. These findings demonstrate that the inhibition of miR-155 holds promise for limiting pancreatitis.",
author = "Jianhua Wan and Xiaoyu Yang and Yuping Ren and Xueyang Li and Yin Zhu and Haddock, {Ashley N.} and Ji, {Baoan D} and Liang Xia and Nonghua Lu",
year = "2019",
month = "4",
day = "1",
doi = "10.1038/s41419-019-1545-x",
language = "English (US)",
volume = "10",
journal = "Cell Death and Disease",
issn = "2041-4889",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Inhibition of miR-155 reduces impaired autophagy and improves prognosis in an experimental pancreatitis mouse model

AU - Wan, Jianhua

AU - Yang, Xiaoyu

AU - Ren, Yuping

AU - Li, Xueyang

AU - Zhu, Yin

AU - Haddock, Ashley N.

AU - Ji, Baoan D

AU - Xia, Liang

AU - Lu, Nonghua

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Acute pancreatitis (AP) is a common digestive disease characterized by inflammation of the pancreas. MiR-155 plays a role in promoting inflammation and inhibiting the activation of anti-inflammatory pathways. Impaired autophagy could promote zymogen activation, abnormal acinar cell secretion, cell death, and the inflammatory response to aggravate AP. The aim of this study was to ascertain the effect of silencing miR-155 on AP through its effects on inflammation and impaired autophagy in vivo. In this study, AAV(adeno-associated virus)-mediated miR-155 and miR-155 sponge were injected through the tail vein of mice. After 3 weeks, AP was induced by intraperitoneal (IP) injections of cerulein. Pancreatic and pulmonary tissues were analyzed after 24 h. Silencing of miR-155 ameliorated pancreas and lung damage in three AP models of mice by preventing accumulation of autophagosomes that are unable to fuse with lysosomes and decreasing pancreatic inflammation by targeting TAB2. 3-MA could reduce the aberrant accumulation of autophagosomes, which alleviates the pancreas damage that was aggravated by increasing miR-155 levels. These findings demonstrate that the inhibition of miR-155 holds promise for limiting pancreatitis.

AB - Acute pancreatitis (AP) is a common digestive disease characterized by inflammation of the pancreas. MiR-155 plays a role in promoting inflammation and inhibiting the activation of anti-inflammatory pathways. Impaired autophagy could promote zymogen activation, abnormal acinar cell secretion, cell death, and the inflammatory response to aggravate AP. The aim of this study was to ascertain the effect of silencing miR-155 on AP through its effects on inflammation and impaired autophagy in vivo. In this study, AAV(adeno-associated virus)-mediated miR-155 and miR-155 sponge were injected through the tail vein of mice. After 3 weeks, AP was induced by intraperitoneal (IP) injections of cerulein. Pancreatic and pulmonary tissues were analyzed after 24 h. Silencing of miR-155 ameliorated pancreas and lung damage in three AP models of mice by preventing accumulation of autophagosomes that are unable to fuse with lysosomes and decreasing pancreatic inflammation by targeting TAB2. 3-MA could reduce the aberrant accumulation of autophagosomes, which alleviates the pancreas damage that was aggravated by increasing miR-155 levels. These findings demonstrate that the inhibition of miR-155 holds promise for limiting pancreatitis.

UR - http://www.scopus.com/inward/record.url?scp=85063933458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063933458&partnerID=8YFLogxK

U2 - 10.1038/s41419-019-1545-x

DO - 10.1038/s41419-019-1545-x

M3 - Article

C2 - 30944299

AN - SCOPUS:85063933458

VL - 10

JO - Cell Death and Disease

JF - Cell Death and Disease

SN - 2041-4889

IS - 4

M1 - 303

ER -